Overview
- Attorney General Ken Paxton filed the case in Panola County District Court alleging deceptive marketing to pregnant women and requesting a jury trial.
- The complaint seeks up to $10,000 per violation in civil penalties and the destruction of materials that portray Tylenol as safe for pregnant women and children.
- Paxton alleges Johnson & Johnson fraudulently shifted Tylenol-related liabilities to its 2023 consumer-health spinoff, Kenvue, to shield assets.
- Kenvue and Johnson & Johnson deny wrongdoing, say independent science shows no proven causal link to autism or ADHD, and pledge to vigorously defend the case.
- The filing follows public warnings from President Donald Trump and HHS Secretary Robert F. Kennedy Jr., as the FDA reviews labeling to note a possible association while stating causation is unproven and after similar federal suits were largely dismissed over expert evidence.